Eyasu H. Teshale

5.9k total citations
133 papers, 3.7k citations indexed

About

Eyasu H. Teshale is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Eyasu H. Teshale has authored 133 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Hepatology, 108 papers in Epidemiology and 31 papers in Infectious Diseases. Recurrent topics in Eyasu H. Teshale's work include Hepatitis C virus research (89 papers), Hepatitis B Virus Studies (63 papers) and Liver Disease Diagnosis and Treatment (55 papers). Eyasu H. Teshale is often cited by papers focused on Hepatitis C virus research (89 papers), Hepatitis B Virus Studies (63 papers) and Liver Disease Diagnosis and Treatment (55 papers). Eyasu H. Teshale collaborates with scholars based in United States, Kenya and Uganda. Eyasu H. Teshale's co-authors include Scott D. Holmberg, Philip R. Spradling, Dale J. Hu, Jan Drobeniuc, Anne C. Moorman, Stuart C. Gordon, Saleem Kamili, Loralee B. Rupp, Joseph A. Boscarino and Mei Lü and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Hepatology.

In The Last Decade

Eyasu H. Teshale

128 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyasu H. Teshale United States 35 2.8k 2.5k 1.1k 271 180 133 3.7k
Jan Drobeniuc United States 28 2.5k 0.9× 1.8k 0.7× 1.0k 0.9× 86 0.3× 103 0.6× 81 3.0k
Francisco Averhoff United States 27 1.4k 0.5× 1.9k 0.7× 611 0.6× 80 0.3× 135 0.8× 91 2.5k
Vana Sypsa Greece 32 1.0k 0.4× 2.1k 0.8× 1.2k 1.2× 184 0.7× 193 1.1× 132 3.4k
Samreen Ijaz United Kingdom 36 5.3k 1.9× 1.4k 0.6× 3.2k 3.0× 110 0.4× 151 0.8× 136 5.9k
Jeffrey J. Post Australia 23 722 0.3× 945 0.4× 502 0.5× 106 0.4× 261 1.4× 95 1.8k
Mark J Ferson Australia 26 353 0.1× 993 0.4× 656 0.6× 156 0.6× 166 0.9× 119 2.0k
Rosa Coppola Italy 22 875 0.3× 998 0.4× 329 0.3× 81 0.3× 240 1.3× 65 1.7k
Sanjay Bhagani United Kingdom 29 1.5k 0.5× 1.7k 0.7× 1.5k 1.4× 140 0.5× 45 0.3× 119 2.9k
Vassiliki Papaevangelou Greece 24 308 0.1× 1.1k 0.4× 412 0.4× 182 0.7× 96 0.5× 131 1.9k
Elisabetta Franco Italy 20 943 0.3× 1.3k 0.5× 657 0.6× 68 0.3× 34 0.2× 113 2.0k

Countries citing papers authored by Eyasu H. Teshale

Since Specialization
Citations

This map shows the geographic impact of Eyasu H. Teshale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyasu H. Teshale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyasu H. Teshale more than expected).

Fields of papers citing papers by Eyasu H. Teshale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyasu H. Teshale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyasu H. Teshale. The network helps show where Eyasu H. Teshale may publish in the future.

Co-authorship network of co-authors of Eyasu H. Teshale

This figure shows the co-authorship network connecting the top 25 collaborators of Eyasu H. Teshale. A scholar is included among the top collaborators of Eyasu H. Teshale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyasu H. Teshale. Eyasu H. Teshale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toy, Mehlika, David W. Hutton, Eyasu H. Teshale, et al.. (2025). Cost-Effectiveness of One-time Universal Testing for Hepatitis D Among Adults With Chronic Hepatitis B in the United States. Clinical Infectious Diseases. 81(4). e211–e217. 4 indexed citations
2.
Chapin-Bardales, Johanna, Alice Asher, Dita Broz, et al.. (2024). Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities—National HIV Behavioral Surveillance, 2018. International Journal of Drug Policy. 144(Pt 1). 104387–104387. 2 indexed citations
3.
Ingviya, Thammasin, Paul K. Sue, Annette M. Jackson, et al.. (2023). Risk factors associated with Hepatitis E virus infection in kidney transplant recipients in a single tertiary Center in the United States. Transplant Immunology. 78. 101809–101809. 3 indexed citations
4.
Striley, Catherine W., et al.. (2022). Hepatitis D‐associated hospitalizations in the United States: 2010–2018. Journal of Viral Hepatitis. 29(3). 218–226. 8 indexed citations
5.
Roberts, Henry, Ruth Jiles, Aaron M. Harris, Neil Gupta, & Eyasu H. Teshale. (2021). Incidence and Prevalence of Sexually Transmitted Hepatitis B, United States, 2013–2018. Sexually Transmitted Diseases. 48(4). 305–309. 16 indexed citations
6.
Ingviya, Thammasin, Eyasu H. Teshale, Saleem Kamili, et al.. (2020). Hepatitis E‐Associated Hospitalizations in the United States: 2010–2015 and 2015–2017. Journal of Viral Hepatitis. 28(4). 672–681. 10 indexed citations
7.
Evans, Mary E., Marissa K. Person, Brigg Reilley, et al.. (2020). Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014. Public Health Reports. 135(4). 461–471. 4 indexed citations
8.
Zhu, Weiming, Gerard P. Aurigemma, Nathan W. Furukawa, et al.. (2020). Infective Endocarditis Among Persons Aged 18–64 Years Living with Human Immunodeficiency Virus, Hepatitis C Infection, or Opioid Use Disorder, United States, 2007−2017. Clinical Infectious Diseases. 72(10). 1767–1781. 27 indexed citations
9.
Teshale, Eyasu H., Alice Asher, Maria Aslam, et al.. (2019). Estimated cost of comprehensive syringe service program in the United States. PLoS ONE. 14(4). e0216205–e0216205. 15 indexed citations
10.
Abara, Winston E., Philip R. Spradling, Anne C. Moorman, et al.. (2019). Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis. Journal of Gastrointestinal Cancer. 51(2). 461–468. 6 indexed citations
11.
Gordon, Stuart C., Sheri Trudeau, Jia Li, et al.. (2017). Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States. Journal of Clinical Gastroenterology. 53(1). 40–50. 15 indexed citations
12.
Vijayadeva, Vinutha, Anne C. Moorman, Loralee B. Rupp, et al.. (2014). Hepatitis B virus infection testing and prevalence among Asian and Pacific Islanders.. PubMed. 20(4). e98–e104. 14 indexed citations
13.
Broz, Dita, Cyprian Wejnert, Thị Thu Hương Phạm, et al.. (2014). HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.. PubMed. 63(6). 1–51. 95 indexed citations
14.
Xeuatvongsa, Anonh, Rita Reyburn, Karen Hennessey, et al.. (2013). Hepatitis B vaccine birthdose practices in a country where hepatitis B is endemic - Laos, December 2011-February 2012.. MMWR Morbidity and Mortality Weekly Report. 62(29). 587–590. 15 indexed citations
15.
Dineen, Brendan, Marian Schilperoord, Stella Gikunju, et al.. (2013). Investigation of Hepatitis E Outbreak Among Refugees — Upper Nile, South Sudan, 2012–2013. MMWR Morbidity and Mortality Weekly Report. 62(29). 581. 69 indexed citations
16.
Teshale, Eyasu H.. (2011). Hepatitis E: Epidemiology and prevention. World Journal of Hepatology. 3(12). 285–285. 82 indexed citations
17.
Howard, Christopher, Thomas Handzel, Vincent R. Hill, et al.. (2010). Novel Risk Factors Associated with Hepatitis E Virus Infection in a Large Outbreak in Northern Uganda: Results from a Case-Control Study and Environmental Analysis. American Journal of Tropical Medicine and Hygiene. 83(5). 1170–1173. 50 indexed citations
18.
Reed, Jason, Debra L. Hanson, A. D. McNaghten, et al.. (2009). HIV Testing Factors Associated with Delayed Entry into HIV Medical Care among HIV-Infected Persons from Eighteen States, United States, 2000–2004. AIDS Patient Care and STDs. 23(9). 765–773. 47 indexed citations
19.
Teshale, Eyasu H., Debra L. Hanson, Brendan Flannery, et al.. (2008). Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998–2003. Vaccine. 26(46). 5830–5834. 42 indexed citations
20.
Hanson, Debra L., et al.. (2007). HIV-infected Injection Drug Users: Health Care Utilization and Morbidity. Journal of Health Care for the Poor and Underserved. 18(3). 675–686. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Drobeniuc Breakdown of academic impact, for papers by Francisco Averhoff Breakdown of academic impact, for papers by Vana Sypsa Breakdown of academic impact, for papers by Samreen Ijaz Breakdown of academic impact, for papers by Jeffrey J. Post Breakdown of academic impact, for papers by Mark J Ferson Breakdown of academic impact, for papers by Rosa Coppola Breakdown of academic impact, for papers by Sanjay Bhagani Breakdown of academic impact, for papers by Vassiliki Papaevangelou Breakdown of academic impact, for papers by Elisabetta Franco
Rankless by CCL
2026